How the LRRK1 protein controls bone remodeling and strength

Molecular Mechanisms of LRRK1 Regulation of Bone Homeostasis

NIH-funded research Loma Linda Veterans Assn Research & Educ · NIH-10996090

This research looks at how changes in the LRRK1 protein affect bone breakdown and could help people with conditions like osteopetrosis or osteoporosis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLoma Linda Veterans Assn Research & Educ NIH-funded
Lab location1 site (Redlands, United States)
Project IDNIH-10996090 on NIH RePORTER

What this research studies

Researchers are studying a protein called LRRK1 that helps control the bone-removing cells known as osteoclasts. They will use laboratory tests and mouse models that lack the LRRK1 gene to see how LRRK1 modifies another protein (OSTM1) and a chloride channel (CLC7) that together allow osteoclasts to dissolve bone. The team will focus on specific chemical tags on OSTM1 that may change how lysosomes release acid into bone pits and thereby control bone resorption. The hope is to map these steps clearly enough to point toward new drug approaches to correct too much or too little bone resorption.

Who could benefit from this research

Good fit: People with osteopetrosis (including Albers-Schonberg disease), other genetic high-bone-mass conditions, or unexplained severe bone density abnormalities would be most likely to connect to this research.

Not a fit: People whose bone or joint problems are unrelated to bone-resorbing cell dysfunction (for example isolated osteoarthritis or bone pain without density changes) are unlikely to benefit directly.

Why it matters

Potential benefit: If successful, this work could identify new drug targets to correct abnormal bone resorption in disorders such as osteopetrosis or osteoporosis.

How similar studies have performed: Previous studies in knockout mice and a reported patient mutation show LRRK1 affects bone resorption, but translating these molecular findings into human treatments is largely novel and untested.

Where this research is happening

Redlands, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Albers-Schoenberg DiseaseAlbers-Schonberg disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.